Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
ATLANTA, Feb. 16, 2017 -- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™.
MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence. MUI Comfort™ has several elements that are central to its patented design including:
- A lightweight collection bag with an integrated drainage neck and secured opening.
- A soft inner liner to protect the skin from perspiration and potential allergenic reaction.
- An enlarged opening with an adjustable closure mechanism that is part of three key elements that prevent accidental leaks, protect the skin, and provide secure fixation.
- A wicking component that draws urine into a superabsorbent-deodorizing polymer and will bond with any liquid to minimize odor, prevent sloshing and leakage.
- Watch the video
“We are excited to be working with the MUCOM team and representing such innovative technology that can provide millions of effected men with a superior management option for their stress, urge, and overflow incontinence,” commented Paul Gianneschi, Managing Principal at Hatch Medical L.L.C.
Donna Lou DuPree McCormack, RN, BSN, President of MUCOM, LLC commented, “We are excited to offer this innovative technology to countless men who are subjected to the embarrassment and social isolation of urinary incontinence, who have been underserved by disappointing products. Our patented technology has the potential to enhance the wellness and quality of life for untold millions of males as they eliminate the use of diapers and pads. We are delighted to be working with Hatch Medical to bring this new technology to the market.”
Founded in 2000, Hatch Medical is an incubator and broker of medical device technologies, assisting clients with development, licensing, distribution and asset sales. For information on this, or other Hatch Medical, L.L.C. products and services, email the company at [email protected]. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site -- http://www.hatchmedical.com.
Contact Paul Gianneschi, Managing Principal, 770-476-9940, Steve Hvozda, Principal 949-388-9335, or Gary Robinson 215-353-0362
